Respiratory syncytial virus with a genomic deficiency complemented in trans
AssigneeDe Staat der Nederlanden, vert. door de minister van VWS
InventorsWillem Luytjes, Myra Noorely Widjojoatmodjo
Life of this patent
Estimating the term…
Loading patent…
AssigneeDe Staat der Nederlanden, vert. door de minister van VWS
InventorsWillem Luytjes, Myra Noorely Widjojoatmodjo
Estimating the term…
The invention relates to pneumoviral virions comprising a viral genome that has a mutation in a gene coding for a protein that is essential for infectivity of the pneumovirus, whereby the mutation causes a virus produced from only the viral genome to lack infectivity, and whereby the virion comprises the protein in a form and in an amount that is required for infectivity of the virion. The invention also relates to methods for producing the pneumoviral virions and for using the virions in the treatment or prevention of pneumoviral infection and disease. A preferred pneumoviral virion is a virion of Respiratory Syncytial Virus in which preferably the gene for the G attachment protein is inactivated and complemented in trans.
A method for producing a vaccine comprising Respiratory Syncytial Virus (RSV) virions comprising (i) a viral genome having a deletion or inactivation of only the gene coding for a G-attachment protein and (ii) a RSV G-attachment protein at its surface, the method comprising:
Dependencies are inferred from the claim text.